HK26584A - Injection solutions containing micelle-forming agents - Google Patents

Injection solutions containing micelle-forming agents

Info

Publication number
HK26584A
HK26584A HK265/84A HK26584A HK26584A HK 26584 A HK26584 A HK 26584A HK 265/84 A HK265/84 A HK 265/84A HK 26584 A HK26584 A HK 26584A HK 26584 A HK26584 A HK 26584A
Authority
HK
Hong Kong
Prior art keywords
solutions containing
forming agents
injection solutions
containing micelle
micelle
Prior art date
Application number
HK265/84A
Other languages
English (en)
Original Assignee
F Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AT511176A external-priority patent/AT352881B/de
Application filed by F Hoffmann-La Roche Ag filed Critical F Hoffmann-La Roche Ag
Publication of HK26584A publication Critical patent/HK26584A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK265/84A 1976-07-12 1984-03-22 Injection solutions containing micelle-forming agents HK26584A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT511176A AT352881B (de) 1976-07-12 1976-07-12 Verfahren zur herstellung von injektions- loesungen
CH699477A CH628811A5 (en) 1976-07-12 1977-06-07 Injection solutions

Publications (1)

Publication Number Publication Date
HK26584A true HK26584A (en) 1984-03-30

Family

ID=25601846

Family Applications (1)

Application Number Title Priority Date Filing Date
HK265/84A HK26584A (en) 1976-07-12 1984-03-22 Injection solutions containing micelle-forming agents

Country Status (18)

Country Link
US (1) US4158707A (enExample)
JP (1) JPS6051448B2 (enExample)
AU (1) AU517249B2 (enExample)
CA (1) CA1082596A (enExample)
DE (1) DE2730570A1 (enExample)
DK (1) DK149483C (enExample)
FR (2) FR2358161A1 (enExample)
GB (1) GB1587076A (enExample)
HK (1) HK26584A (enExample)
IE (1) IE46037B1 (enExample)
IL (1) IL52458A (enExample)
IT (1) IT1202370B (enExample)
LU (2) LU77708A1 (enExample)
MY (1) MY8500263A (enExample)
NL (1) NL189072C (enExample)
NZ (1) NZ184564A (enExample)
PH (1) PH16333A (enExample)
SE (1) SE448516B (enExample)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2914788A1 (de) * 1979-04-11 1980-10-16 Nattermann A & Cie Parenteral applizierbare, stabile arzneimittelloesungen mit entzuendungshemmender wirkung
CA1173360A (en) * 1979-06-22 1984-08-28 Jurg Schrank Pharmaceutical preparations
US4264583A (en) * 1979-07-25 1981-04-28 The Procter & Gamble Company Gallstone dissolution compositions and method
JPS57163313A (en) * 1981-03-31 1982-10-07 Nippon Shinyaku Co Ltd Vitamin e pharmaceutical and its preparation
JPH0768117B2 (ja) * 1983-05-06 1995-07-26 ベスター・インコーポレイテツド 薬剤放出調整用小胞製剤
US4649155A (en) * 1983-07-22 1987-03-10 Hoffmann-La Roche Inc. Injectable solutions
JPH0818989B2 (ja) * 1984-01-12 1996-02-28 株式会社ミドリ十字 脂肪乳剤中のプロスタグランジンの安定化方法
CA1264162A (en) * 1984-03-15 1990-01-02 Manfred Breuninger Glycerol ether phosphatides
US5002936A (en) * 1985-04-12 1991-03-26 Seymour Lieberman Lipophilic complexes of pharmacologically active inorganic mineral acid esters of organic compounds
KR860008777A (ko) * 1985-05-02 1986-12-18 고르든 베. 휴에첸 항 비루스성 및 항 종양성인 의약 조성물 및 그 제조방법
US4831018A (en) * 1985-05-17 1989-05-16 Smithkline Beckman Corporation Polyene antibiotic emulsion formulation
US5023271A (en) * 1985-08-13 1991-06-11 California Biotechnology Inc. Pharmaceutical microemulsions
SE8505047L (sv) * 1985-10-25 1987-04-26 Nutritional Int Res Inst Fettemulsion
CA1319886C (en) * 1987-02-03 1993-07-06 Alberto Ferro Mixed micelle solutions
DE3903753A1 (de) * 1989-02-06 1990-08-23 Schering Ag Verfahren zur herstellung waessriger mischmicelloesungen
NZ232865A (en) * 1989-03-21 1992-07-28 Hoffmann La Roche A mixed-micelle solution comprising a micelle former and an immunomodulator
US5085864A (en) * 1989-10-30 1992-02-04 Abbott Laboratories Injectable formulation for lipophilic drugs
DE3938030A1 (de) * 1989-11-13 1991-05-16 Schering Ag Verfahren zur herstellung waessriger mischmicelloesungen
CA2033725C (en) * 1990-01-24 2001-05-29 Folker Pittrof Pharmaceutical and cosmetic compositions containing a salt of cholanic acid
CA2033714A1 (en) * 1990-01-25 1991-07-26 Alberto Ferro Pharmaceutical preparations
FR2663224B1 (fr) * 1990-06-14 1995-01-20 Applicationes Farmaceuticas Sa Forme galenique parenterale.
DE4122661C2 (de) * 1990-08-06 1996-07-11 Nattermann A & Cie Pharmazeutisches Produkt zur Behandlung von Pneumocystis-carinii-Pneumonie
EP0471309A1 (de) * 1990-08-17 1992-02-19 F. Hoffmann-La Roche Ag Verwendung von Mischmicellen
EP0570519B1 (en) * 1991-02-08 1999-05-06 Pro-Neuron, Inc. Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis
DE4336434A1 (de) * 1993-10-26 1995-04-27 Hoechst Ag Pharmazeutische Zubereitung für die parenterale, enterale und dermale Verabreichung von praktisch unlöslichen Arzneistoffen und Verfahren zu ihrer Herstellung
EP0682943B1 (de) * 1994-05-20 2003-08-20 GESELLSCHAFT FÜR MEDIZINISCHE FORSCHUNG UND WEITERBILDUNG e.V. GMF Lormetazepamhaltige Öl-in-Wasser-Emulsion
GB9426104D0 (en) * 1994-12-23 1995-02-22 Merck Sharp & Dohme Use of surfactants and emulsions
JP2740153B2 (ja) * 1995-03-07 1998-04-15 エフ・ホフマン−ラ ロシユ アーゲー 混合ミセル
US5759445A (en) * 1995-05-24 1998-06-02 Matsushita Electric Industrial Co., Ltd. Lipid-dispersed solution and process for producing the same
GB2326337A (en) 1997-06-20 1998-12-23 Phares Pharma Holland Homogeneous lipid compositions for drug delivery
US6350738B1 (en) 1998-03-06 2002-02-26 Brigham Young University Steroid derived antibiotics
US6767904B2 (en) 1998-03-06 2004-07-27 Bringham Young University Steroid derived antibiotics
ES2332584T3 (es) * 2001-03-27 2010-02-09 Phares Pharmaceutical Research N.V. Metodo y composicion para solubilizar un compuesto biologicamente activo con baja solubilidad en agua.
US7611630B2 (en) * 2004-03-30 2009-11-03 Bend Research, Inc. Method and device for evaluation of pharmaceutical compositions
US7754230B2 (en) * 2004-05-19 2010-07-13 The Regents Of The University Of California Methods and related compositions for reduction of fat
EP1758590B1 (en) * 2004-05-19 2011-08-24 Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center Use of a detergent for the non-surgical removal of fat
US20060127468A1 (en) * 2004-05-19 2006-06-15 Kolodney Michael S Methods and related compositions for reduction of fat and skin tightening
US20100062073A1 (en) * 2006-11-29 2010-03-11 Ronald Arthur Beyerinck Pharmaceutical compositions comprising nanoparticles comprising enteric polymers casein
WO2008125940A2 (en) * 2007-04-17 2008-10-23 Pfizer Products Inc. Nanoparticles comprising non-crystalline drug
US8309129B2 (en) * 2007-05-03 2012-11-13 Bend Research, Inc. Nanoparticles comprising a drug, ethylcellulose, and a bile salt
WO2008135855A2 (en) * 2007-05-03 2008-11-13 Pfizer Products Inc. Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and a nonionizable polymer
US20100080852A1 (en) * 2007-05-03 2010-04-01 Ronald Arthur Beyerinck Phamaceutical composition comprising nanoparticles and casein
US8974827B2 (en) * 2007-06-04 2015-03-10 Bend Research, Inc. Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer
WO2008149230A2 (en) 2007-06-04 2008-12-11 Pfizer Products Inc. Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glycol succinate
EP2178518A2 (en) * 2007-07-13 2010-04-28 Bend Research, Inc Nanoparticles comprising ionizable, poorly water soluble cellulosic polymers
EP2240162A4 (en) * 2007-12-06 2013-10-09 Bend Res Inc NANOTE PARTICLES WITH A NON-IONIZABLE POLYMER AND AN AMIN-FUNCTIONALIZED METHACRYLATE COPOLYMER
EP2231169B1 (en) * 2007-12-06 2016-05-04 Bend Research, Inc. Pharmaceutical compositions comprising nanoparticles and a resuspending material
US8101593B2 (en) 2009-03-03 2012-01-24 Kythera Biopharmaceuticals, Inc. Formulations of deoxycholic acid and salts thereof
CN102058528B (zh) * 2009-11-13 2012-12-12 中国科学院上海药物研究所 一种黄豆苷元胶束及其制备方法
GB2480632A (en) 2010-05-25 2011-11-30 Kythera Biopharmaceuticals Inc Preparation of 12-keto and 12-alpha-hydroxy steroids
MX363465B (es) 2011-02-18 2019-03-25 Kythera Biopharmaceuticals Inc Tratamiento de la grasa submental.
US8653058B2 (en) 2011-04-05 2014-02-18 Kythera Biopharmaceuticals, Inc. Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits
BR112014029188B1 (pt) * 2012-05-31 2020-02-11 Terumo Kabushiki Kaisha Veículo sensível ao ph e método de preparação do mesmo, e droga sensível ao ph e composição medicamentosa sensível ao ph contendo o veículo, e método de cultura usando o mesmo
US9321749B1 (en) 2012-07-25 2016-04-26 Globavir Biosciences, Inc. Heterocyclic compounds and uses thereof
CN104884064A (zh) 2012-12-24 2015-09-02 纽洛佳斯特拉斯公司 用于治疗胃肠道病症的方法
WO2015200369A1 (en) 2014-06-24 2015-12-30 Neurogastrx, Inc. Prodrugs of metopimazine
CN110876719B (zh) * 2018-09-06 2022-08-09 中国人民解放军军事科学院军事医学研究院 一种维生素k1注射剂及其制备方法
US10836757B1 (en) 2020-04-02 2020-11-17 Neurogastrx, Inc. Polymorphic forms of metopimazine

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE575616C (de) * 1928-12-14 1933-04-29 Hans Much Dr Verfahren zur Herstellung bestaendiger, klarer, waessriger Loesungen von Lipoiden, Fetten oder Harzen
GB706607A (en) 1951-07-31 1954-03-31 Roche Products Ltd Process for the manufacture of dispersable solutions of fat soluble vitamins
DE932083C (de) * 1954-03-31 1955-08-22 Upha Chem Pharm Praeparate G M Verfahren zur Herstellung stabiler waessriger Injektionsloesungen von 2-Methyl-5, 8-dimethoxy-furanochromon
DE1089510B (de) * 1959-03-23 1960-09-22 Rudolf Reiss Dr Verfahren zur Herstellung waessriger, injizierbarer Loesungen von 2-Methoxy-4-allylphenoxyessigsaeure-N, N-Diaethylamid
US3044931A (en) * 1960-01-27 1962-07-17 Geigy Chem Corp Aryloxy acetic acid amides: process for parenteral application
NL126750C (enExample) * 1960-12-05
US3639597A (en) * 1968-02-02 1972-02-01 Merck & Co Inc Pharmaceutical compositions containing cholanic acid conjugates
GB1317184A (en) * 1969-06-20 1973-05-16 Glaxo Lab Ltd Steroid-containing pharmaceutical preparations
US3900561A (en) * 1970-12-17 1975-08-19 Glaxo Lab Ltd Pharmaceutical compositions
US3917830A (en) * 1970-12-17 1975-11-04 Glaxo Lab Ltd Steroidal anaesthetic composition for intraveneous injection
US4017616A (en) * 1972-01-21 1977-04-12 American Home Products Corporation Parenteral benzodiazepine compositions
AU461715B2 (en) * 1972-01-21 1975-05-19 American Home Products Corporation Parenteral benzodiazepine compositions
DE2315609A1 (de) * 1973-03-29 1974-10-17 Holzhueter Hermann Verfahren zum loesen von indomethacin in wasser und eine indomethacin enthaltende pharmazeutische zubereitung zur parenteralen applikation
DE2433173C3 (de) * 1974-07-10 1980-02-07 J. Pfrimmer & Co, 8520 Erlangen Verwendung von Cholansaurederivaten

Also Published As

Publication number Publication date
LU90037I2 (fr) 1997-06-13
AU2684677A (en) 1979-01-11
DK149483C (da) 1986-12-15
NL189072C (nl) 1993-01-04
FR2423219B1 (enExample) 1980-10-24
DK314777A (da) 1978-01-13
PH16333A (en) 1983-09-05
DE2730570A1 (de) 1978-01-19
JPS6051448B2 (ja) 1985-11-14
IE771403L (en) 1978-01-12
CA1082596A (en) 1980-07-29
LU77708A1 (enExample) 1978-09-14
GB1587076A (en) 1981-03-25
AU517249B2 (en) 1981-07-16
NZ184564A (en) 1979-12-11
FR2423219A1 (fr) 1979-11-16
SE7708059L (sv) 1978-01-13
FR2358161B1 (enExample) 1980-07-25
SE448516B (sv) 1987-03-02
JPS539314A (en) 1978-01-27
US4158707A (en) 1979-06-19
DE2730570C2 (enExample) 1989-01-19
NL7707641A (nl) 1978-01-16
IE46037B1 (en) 1983-02-09
NL189072B (nl) 1992-08-03
MY8500263A (en) 1985-12-31
IL52458A0 (en) 1977-10-31
DK149483B (da) 1986-06-30
IL52458A (en) 1980-10-26
FR2358161A1 (fr) 1978-02-10
IT1202370B (it) 1989-02-09

Similar Documents

Publication Publication Date Title
HK26584A (en) Injection solutions containing micelle-forming agents
IE792216L (en) Colloidal lipid pharmaceutical composition containing¹dihexanoyl lecithin
NL183032C (nl) Werkwijze ter bereiding van farmaceutisch werkzame n-gesubstitueerde 4,5,6,7-tetrahydrothieno-pyridinederivaten, alsmede werkwijze ter bereiding van een farmaceutisch preparaat en farmaceutisch voorwerp.
NL191508C (nl) Farmaceutisch preparaat, dat tenminste één glycinamidederivaat bevat, alsmede glycinamide derivaat, dat geschikt is voor gebruik in een zodanig preparaat.
CA2033725A1 (en) Pharmaceutical and cosmetic compositions containing a salt of cholanic acid
HK110093A (en) Phenyl carbamate
NL178320C (nl) Werkwijze voor het bereiden van een verbinding met histamino-hŸ2-blokkerende activiteit en voor het bereiden van farmaceutische preparaten, die deze verbinding bevatten.
IE801281L (en) Parental administration using liposomes
MX9203504A (es) Complejo agente: lipido activo de alta proporcion.
JPS5238017A (en) Immunological medicine being active in aqueous solution
NL7708325A (nl) Fosforzuurderivaten, werkwijze voor de berei- ding daarvan en werkwijze voor het bereiden van een daarop gebaseerd geneesmiddel.
JPS5231839A (en) Drug for cosmetics and permanent wave in combination
PT65244B (en) Pharmaceutically active complexes and pharmaceutical compositions containing them
NL182878C (nl) Werkwijze voor de bereiding van een farmaceutisch preparaat dat dicarbonzuuresters van epinine bevat, farmacotherapeutisch voorwerp, alsmede werkwijze voor de bereiding van geneeskrachtige verbindingen, geschikt voor gebruik in deze preparaten en voorwerpen.
DE2966411D1 (en) Imidazolylvinylethers, their preparation and application as active agent in pharmaceutical and biocidal compositions
PH11669A (en) Thienobenzo(1,5)diazepine derivatives and the pharmaceutical formulation thereof
FR2332999A1 (fr) Derives d'oestradiol, leur preparation et leur application comme medicaments antioestrogenes
NL7701810A (nl) Werkwijze voor het bereiden van een geneesmiddel met een anti-neoplastische activiteit, werkwij- ze voor de bereiding van de actieve component en gevormd preparaat.
IL52792A (en) 5-substituted-4-amino-thiophene-3-carboxylic acid derivatives,their preparation and antiobesity and blood lipid lowering pharmaceutical compositions containing them
NL7711015A (nl) Werkwijze voor de bereiding van een farmaceutisch preparaat, werkwijze voor de bereiding van een farmaceutisch actieve stof en gevormd farmaceu- tisch preparaat.
USD245416S (en) Combined wheel chock and flag
IL52820A (en) Acylated benzimidazole-2-methanol and-2-carboxylic acid derivatives, their preparation and pharmaceutical compositions containing them
NL160722C (nl) Werkwijze ter bereiding van een farmaceutisch preparaat door een 6,6-difluorsteroide in een voor therapeutische toediening geschikte vorm te brengen, alsmede gevormd preparaat en werkwijze ter bereiding van de werkzame verbindingen.
NL157501C (nl) Farmaceutisch tablet dat een combinatie bevat van een 2,4-diamino-5-benzylpyrimidinederivaat met een sulfonamide, beide gemicroniseerd, naast ten minste een splijtmiddel en een granuleringsmiddel, alsmede werk- wijze voor het bereiden van een dergelijk tablet.
IE33207L (en) Pharmaceutical compositions containing diazacarbazole

Legal Events

Date Code Title Description
NR Patent deemed never to have been added to the register under section 13(7) of patents (transitional arrangements) rules